3XIAO Xueyuan1, ZHAO Xiaodong2, LIU Jiankai3, GUO Fuzheng1, LIU Danhui1 & HE Dacheng1 1. Key Laboratory for Cell Proliferation and Regulation Biology, Ministry of Education, Beijing Normal University, Universities?Confeder-ated Institute of Proteomics, Beijing 100875, China,2. Department of Otolaryngology-Head and Neck Surgery, Third Affiliated Hospital, Jilin University, Changchun 130031, China,3. Department of Biochemistry, Jilin University, Changchun 130021, China.Discovery of laryngeal carcinoma by serum proteomic pattern analysis[J].Science China(Life Sciences),2004,47(3):219-223. 被引量：22
2Wiesner A. Detection of tumor markers with proteinchip technology. Curr Pharm Biotechnol, 2004,5:45-67.
3Qu Y, Adam BL, Yasui Y, et al. Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients. Clin Chem, 2002,48:1835-1843.
4Wright GL. SELDI proteinchip MS: a platform for biomarker discovery and cancer diagnosis. Expert Rev Mol Diagn, 2002,2:549-563.
5DeAngelis LM. Brain tumors. N Engl J Med, 2001,344:114-123.
6Samoylova TI, Morrison NE, Cox NR. Molecular markers of glial tumors: current targeting strategies. Curr Med Chem, 2003,10:831-843.
7Erick K, James H, Schwarts TM, et al. Principles of Neural Science. 4th edition.Chicago: The Chicago University of Press, 2001. 1288-1301.
8Koike A, Takagi T. Prediction of protein-protein interaction sites using support vector machines. Protein Eng Des Sel 2004;17:165-173.
9Church TR, Yeazel MW, Jones RM, Kochevar LK, Watt GD,Mongin SJ, Cordes JE, Engelhard D. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening. J Natl Cancer Inst 2004; 96:770-780.
10Kornek GV, Depisch D, Rosen HR, Temsch EM, Scheithauer W.Comparative analysis of CA72-4, CA195 and carcinoembryonic antigen in patients with gastrointestinal malignancies. J Cancer Res Clin Oncol 1992; 118:318-320.
